Opinion|Videos|April 3, 2025
Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights
Experts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.
Advertisement
Episodes in this series
Advertisement
Related to this article
ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.
Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Reframing Nurse Fatigue as Systemic Safety Risk
2
Psychedelic Medicine in Cancer Care: What Nursing Teams Need to Know
3
FDA Approves Belzutifan Plus Lenvatinib for Advanced Clear Cell RCC
4
ICN 2026: APP Leadership, Cancer Pain Care, and Nurse-Led Rapid Care Models
5